Scholar Rock Holding (SRRK) Other financing activities (2018 - 2026)

Scholar Rock Holding's (SRRK) quarterly Other financing activities came in at $3.5 million in Q1 2026, down 30.82% year-on-year from $5.0 million in Q1 2025, and down 85.41% quarter-over-quarter from $23.8 million in Q4 2025.

Scholar Rock Holding (SRRK) Other financing activities (2018 - 2026) Analysis & Trends

Scholar Rock Holding's Other financing activities history runs 9 years deep, the most recent figure standing at $3.5 million for Q1 2026.

  • On a quarterly basis, Other financing activities fell 30.82% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $22.3 million, a 56.5% increase from a year earlier, with the FY2025 full-year figure at $23.8 million, up 147.39% from the prior year.
  • Other financing activities slipped to $3.5 million in Q1 2026 per SRRK's latest filing, from $23.8 million in the prior quarter.
  • Across five years, Other financing activities topped out at $23.8 million in Q4 2025 and bottomed at -$3.4 million in Q3 2025.
  • The 5-year median for Other financing activities is $419000.0 (2024), against an average of $2.7 million.
  • Across the five-year window, Other financing activities jumped 568600.0% in 2024 and plunged 129.07% in 2025, its largest moves.
  • Year by year, Other financing activities stood at $5000.0 in 2022, then jumped by 69100.0% to $3.5 million in 2023, then climbed by 1.71% to $3.5 million in 2024, then surged by 576.58% to $23.8 million in 2025, then slumped by 85.41% to $3.5 million in 2026.
  • Per Business Quant, the three latest SRRK Other financing activities figures stand at $3.5 million (Q1 2026), $23.8 million (Q4 2025), and -$3.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Scholar Rock Holding 6.30 Bn 6.30 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.47 Mn
Mar 31, 2026 3.47 Mn
Dec 31, 2025 23.81 Mn
Dec 31, 2025 23.81 Mn
Sep 30, 2025 -3.37 Mn
Sep 30, 2025 -3.37 Mn
Jun 30, 2025 -1.65 Mn
Jun 30, 2025 -1.65 Mn
Mar 31, 2025 5.02 Mn
Mar 31, 2025 5.02 Mn
Dec 31, 2024 3.52 Mn
Dec 31, 2024 3.52 Mn
Jun 30, 2024 5.69 Mn
Jun 30, 2024 5.69 Mn
Mar 31, 2024 419,000.00
Mar 31, 2024 419,000.00
Dec 31, 2023 3.46 Mn
Dec 31, 2023 3.46 Mn
Jun 30, 2023 1,000.00
Jun 30, 2023 1,000.00